Evexia Lifecare Ltd

Evexia Lifecare Ltd share price softened by 4.71% to Rs 1.82 after the company's net profit plunged by 45.24% to Rs 0.23 crore, while revenue from operations declined 19% to Rs 25.02 crore in Q3FY26 over Q2FY26. The market capitalization of Trading - Chemicals industry group stocks on BSE stood at Rs 3120.47 crore, expanding by 34.75%. It has slipped by 5.37% over last one week and eased lower by 5.71% in last one month while the market capitalization of Evexia Lifecare Ltd has reduced by 13.75% and 38.73% in the same period respectively. Profit before tax (PBT) of Evexia Lifecare Ltd stood at Rs 0.37 crore in Q3 FY26, tanking 27.45% year-on-year, and crashing by 35.09% quarter-on-quarter. EBITDA came in at Rs 1 crore, surging by 171.88% YoY and tumbling by 328.95% sequentially. Total expenses fell by 16.70% to Rs 25.38 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 0.1 crore, jumping 150% YoY, while employee benefits expense was at Rs 1.02 crore, soaring 1600% YoY. For the TTM ended FY26, revenue from operations contracted by 19.07% to Rs 56.29 crore, while net profit saw a strong growth of 105.97% to Rs 1.38 crore, compared to previous TTM. EBITDA tanked by 227% to Rs 1.11 crore, and PBT witnessed a strong rise of 26.14% to Rs 1.93 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 17.02 crore in FY26, as against Rs 3.15 crore in FY25. Evexia Lifecare Ltd crashed 8.08% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 13.52% during the same period.

Evexia Lifecare Ltd share price declined by 4.98% to Rs 1.91 after the company's net profit tumbled by 46.15% to Rs 0.42 crore, while revenue from operations slipped 16.04% to Rs 30.89 crore in Q2FY26 over Q1FY26. The market capitalization of Trading - Chemicals industry group stocks on BSE stood at Rs 3163.72 crore, jumping 34.55%. It has softened by 3.81% over last one week and edged lower by 4.85% in last one month while the market capitalization of Evexia Lifecare Ltd has slipped by 13.57% and 41.93% in the same period respectively. Profit before tax (PBT) of Evexia Lifecare Ltd stood at Rs 0.57 crore in Q2 FY26, tumbling by 33.72% year-on-year, and plunging by 36.67% quarter-on-quarter. EBITDA came in at Rs 0 crore, crashing by 64.49% YoY and tanking 62.00% sequentially. Total expenses fell by 15.31% to Rs 30.47 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 0.04 crore, remained flat YoY, while employee benefits expense was at Rs 0.06 crore, collapsing by 82.86% YoY. For the TTM ended FY26, revenue from operations dropped by 19.07% to Rs 56.29 crore, while net profit surged by 105.97% to Rs 1.38 crore, compared to previous TTM. EBITDA saw a sharp decline of 227% to Rs 1.11 crore, and PBT soared 26.14% to Rs 1.93 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 17.02 crore in FY26, as against Rs 3.15 crore in FY25. Evexia Lifecare Ltd slipped 3.54% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 13.37% during the same period.

Evexia Lifecare Ltd share price softened by 4.74% to Rs 2.01 after the company's net profit tanked by 46.15% to Rs 0.42 crore, while revenue from operations declined 16.04% to Rs 30.89 crore in Q2FY26 over Q1FY26. The market capitalization of Trading - Chemicals industry group stocks on BSE stood at Rs 3163.72 crore, expanding by 34.55%. It has eased by 3.30% over last one week and softened by 4.12% in last one month while the market capitalization of Evexia Lifecare Ltd has slipped by 10.27% and 49.36% in the same period respectively. Profit before tax (PBT) of Evexia Lifecare Ltd stood at Rs 0.57 crore in Q2 FY26, tanking 33.72% year-on-year, and nosediving by 36.67% quarter-on-quarter. EBITDA came in at Rs 0 crore, tumbling by 64.49% YoY and crashing by 62.00% sequentially. Total expenses fell by 15.31% to Rs 30.47 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 0.04 crore, remained flat YoY, while employee benefits expense was at Rs 0.06 crore, collapsing by 82.86% YoY. For the TTM ended FY26, revenue from operations contracted by 19.07% to Rs 56.29 crore, while net profit saw a strong growth of 105.97% to Rs 1.38 crore, compared to previous TTM. EBITDA saw a sharp decline of 227% to Rs 1.11 crore, and PBT soared 26.14% to Rs 1.93 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 17.02 crore in FY26, as against Rs 3.15 crore in FY25. Evexia Lifecare Ltd slipped 1.47% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 12.69% during the same period.

Evexia Lifecare Limited will hold a board meeting on Saturday, October 24, 2026, to consider and approve the unaudited financial results (standalone & consolidated) for the quarter and six months ended September 30, 2026, according to a filing with the BSE. The trading window closure period will end 48 hours after the results are made public.

Evexia Lifecare Limited announced that its board of directors appointed Mr. Sagar Sandeep Pagariya as Company Secretary & Compliance Officer, designated as Key Managerial Personnel, effective October 14, 2026.

Evexia Lifecare Limited announced that its Board of Directors appointed Mr. Sagar Sandeep Pagariya (ACS: 62781) as Company Secretary & Compliance officer (KMP) effective October 14, 2026, according to a regulatory filing on October 13, 2026.

EvExia Lifecare Limited submitted a certificate to the BSE Ltd. regarding the dematerialization and rematerialization of its securities for the quarter ended September 30, 2026, as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, with confirmation from MUFG Intime India Private Limited, formerly Link Intime India Private Limited, acting as the company's Registrar and Share Transfer Agent.

Evexia Lifecare Limited informed the BSE Ltd. that the trading window for its equity shares will be closed from October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter and half-year ended September 30, 2026, for all designated persons and their immediate relatives.

Evexia Lifecare Limited informed the BSE that its board of directors approved the conversion of 50 foreign currency convertible bonds into equity shares at a meeting held on September 11, 2026, following approval from shareholders at the Annual General Meeting on July 9, 2022.

EVEXIA LIFECARE LIMITED has informed the BSE that the record date for the purpose of Notice and e-voting for its 35th Annual General Meeting, to be held on September 30, 2026, is set as September 4, 2026, and September 25, 2026, respectively, for equity security holders.